-
2
-
-
24344448276
-
Stratum corneum defensive functions: an integrated view
-
Elias P.M. Stratum corneum defensive functions: an integrated view. J. Invest. Dermatol. 125 (2005) 183-200
-
(2005)
J. Invest. Dermatol.
, vol.125
, pp. 183-200
-
-
Elias, P.M.1
-
3
-
-
0043175485
-
What is the 'true' function of skin?
-
Chuong C.M., et al. What is the 'true' function of skin?. Exp. Dermatol. 11 (2002) 159-187
-
(2002)
Exp. Dermatol.
, vol.11
, pp. 159-187
-
-
Chuong, C.M.1
-
4
-
-
34250640648
-
The regulation of permeability barrier homeostasis
-
Feingold K.R., et al. The regulation of permeability barrier homeostasis. J. Invest Dermatol. 127 (2007) 1574-1576
-
(2007)
J. Invest Dermatol.
, vol.127
, pp. 1574-1576
-
-
Feingold, K.R.1
-
6
-
-
0035734317
-
New aspects of the skin barrier organization
-
Bouwstra J., et al. New aspects of the skin barrier organization. Skin Pharmacol. Appl. Skin Physiol. 14 Suppl. 1 (2001) 52-62
-
(2001)
Skin Pharmacol. Appl. Skin Physiol.
, vol.14
, Issue.SUPPL. 1
, pp. 52-62
-
-
Bouwstra, J.1
-
7
-
-
0035733348
-
Modulation of the barrier function of the skin
-
Hadgraft J. Modulation of the barrier function of the skin. Skin Pharmacol. Appl. Skin Physiol. 14 Suppl. 1 (2001) 72-81
-
(2001)
Skin Pharmacol. Appl. Skin Physiol.
, vol.14
, Issue.SUPPL. 1
, pp. 72-81
-
-
Hadgraft, J.1
-
8
-
-
0034098046
-
The 500 Dalton rule for the skin penetration of chemical compounds and drugs
-
Bos J.D., et al. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp. Dermatol. 9 (2000) 165-169
-
(2000)
Exp. Dermatol.
, vol.9
, pp. 165-169
-
-
Bos, J.D.1
-
9
-
-
34247497220
-
Nanoparticles - an efficient carrier for drug delivery into the hair follicles
-
Lademann J., et al. Nanoparticles - an efficient carrier for drug delivery into the hair follicles. Eur. J. Pharm. Biopharm. 66 (2007) 159-164
-
(2007)
Eur. J. Pharm. Biopharm.
, vol.66
, pp. 159-164
-
-
Lademann, J.1
-
10
-
-
33746332341
-
Hair follicles - a long-term reservoir for drug delivery
-
Lademann J., et al. Hair follicles - a long-term reservoir for drug delivery. Skin Pharmacol. Physiol. 19 (2006) 232-236
-
(2006)
Skin Pharmacol. Physiol.
, vol.19
, pp. 232-236
-
-
Lademann, J.1
-
11
-
-
40549093373
-
The role of hair follicles in percutaneous absorption of caffeine
-
Otberg N., et al. The role of hair follicles in percutaneous absorption of caffeine. Br. J. Clin. Pharmacol. 65 (2008) 488-492
-
(2008)
Br. J. Clin. Pharmacol.
, vol.65
, pp. 488-492
-
-
Otberg, N.1
-
12
-
-
0037622077
-
Water distribution and related morphology in human stratum corneum at different hydration levels
-
Bouwstra J.A., et al. Water distribution and related morphology in human stratum corneum at different hydration levels. J. Invest. Dermatol. 120 (2003) 750-758
-
(2003)
J. Invest. Dermatol.
, vol.120
, pp. 750-758
-
-
Bouwstra, J.A.1
-
13
-
-
34447505927
-
Pimecrolimus versus topical corticosteroids in dermatology
-
Korfitis C., et al. Pimecrolimus versus topical corticosteroids in dermatology. Expert. Opin. Pharmacother. 8 (2007) 1565-1573
-
(2007)
Expert. Opin. Pharmacother.
, vol.8
, pp. 1565-1573
-
-
Korfitis, C.1
-
14
-
-
17444403911
-
Topical antibiotics in skin infections
-
Thaci D., et al. Topical antibiotics in skin infections. Hautarzt 56 (2005) 381-394
-
(2005)
Hautarzt
, vol.56
, pp. 381-394
-
-
Thaci, D.1
-
15
-
-
32944460974
-
Dermatophytosis: the management of fungal infections
-
Gupta A., et al. Dermatophytosis: the management of fungal infections. SKINmed. 4 (2005) 305-310
-
(2005)
SKINmed.
, vol.4
, pp. 305-310
-
-
Gupta, A.1
-
16
-
-
0036836251
-
Vitamin D and topical therapy
-
Lebwohl M. Vitamin D and topical therapy. Cutis 70 (2002) 5-8
-
(2002)
Cutis
, vol.70
, pp. 5-8
-
-
Lebwohl, M.1
-
17
-
-
33749142331
-
Update in retinoid therapy of acne
-
Thielitz A., et al. Update in retinoid therapy of acne. Dermatol. Ther. 19 (2006) 272-279
-
(2006)
Dermatol. Ther.
, vol.19
, pp. 272-279
-
-
Thielitz, A.1
-
19
-
-
33748919078
-
Classical topical therapy of psoriasis
-
Gerdes S., et al. Classical topical therapy of psoriasis. Hautarzt 57 (2006) 666-671
-
(2006)
Hautarzt
, vol.57
, pp. 666-671
-
-
Gerdes, S.1
-
20
-
-
34247201535
-
Acquired palmoplantar keratoderma
-
Patel S., et al. Acquired palmoplantar keratoderma. Am. J. Clin. Dermatol. 8 (2007) 1-11
-
(2007)
Am. J. Clin. Dermatol.
, vol.8
, pp. 1-11
-
-
Patel, S.1
-
21
-
-
34548274657
-
Assigning new roles to topical tacrolimus
-
Rallis E., et al. Assigning new roles to topical tacrolimus. Expert Opin. Investig. Drugs 16 (2007) 1267-1276
-
(2007)
Expert Opin. Investig. Drugs
, vol.16
, pp. 1267-1276
-
-
Rallis, E.1
-
22
-
-
0036901112
-
Rapid and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies
-
Haas N., et al. Rapid and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies. Arch. Dermatol. 138 (2002) 1618-1619
-
(2002)
Arch. Dermatol.
, vol.138
, pp. 1618-1619
-
-
Haas, N.1
-
23
-
-
0033038592
-
Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies
-
Chouela E.N., et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch. Dermatol. 135 (1999) 651-655
-
(1999)
Arch. Dermatol.
, vol.135
, pp. 651-655
-
-
Chouela, E.N.1
-
24
-
-
0346504108
-
Inside-out application of ivermectin in scabies - a hypothesis
-
Haas N., et al. Inside-out application of ivermectin in scabies - a hypothesis. J. Dtsch. Dermatol. Ges. 1 (2003) 933-937
-
(2003)
J. Dtsch. Dermatol. Ges.
, vol.1
, pp. 933-937
-
-
Haas, N.1
-
25
-
-
0028283024
-
Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days
-
Faergemann J., et al. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin. Exp. Dermatol. 19 (1994) 121-126
-
(1994)
Clin. Exp. Dermatol.
, vol.19
, pp. 121-126
-
-
Faergemann, J.1
-
26
-
-
0023883954
-
Pharmacokinetic profile of orally administered itraconazole in human skin
-
Cauwenbergh G., et al. Pharmacokinetic profile of orally administered itraconazole in human skin. J. Am. Acad. Dermatol. 18 (1988) 263-268
-
(1988)
J. Am. Acad. Dermatol.
, vol.18
, pp. 263-268
-
-
Cauwenbergh, G.1
-
27
-
-
0025077803
-
Pharmacology of the allylamines
-
Birnbaum J.E. Pharmacology of the allylamines. J. Am. Acad. Dermatol. 23 (1990) 782-785
-
(1990)
J. Am. Acad. Dermatol.
, vol.23
, pp. 782-785
-
-
Birnbaum, J.E.1
-
28
-
-
0025850643
-
Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat
-
Faergemann J., et al. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Derm. Venereol. 71 (1991) 322-326
-
(1991)
Acta Derm. Venereol.
, vol.71
, pp. 322-326
-
-
Faergemann, J.1
-
29
-
-
0027328120
-
Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks
-
Faergemann J., et al. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks. Acta Dermatol. Venereol. 73 (1993) 305-309
-
(1993)
Acta Dermatol. Venereol.
, vol.73
, pp. 305-309
-
-
Faergemann, J.1
-
30
-
-
0002961839
-
Antifungal combination therapy: where we stand
-
Sugar A.M. Antifungal combination therapy: where we stand. Drug Resist. Updat. 1 (1998) 89-92
-
(1998)
Drug Resist. Updat.
, vol.1
, pp. 89-92
-
-
Sugar, A.M.1
-
31
-
-
0021045462
-
Orally administered ketoconazole: route of delivery to the human stratum corneum
-
Harris R., et al. Orally administered ketoconazole: route of delivery to the human stratum corneum. Antimicrob. Agents Chemother. 24 (1983) 876-882
-
(1983)
Antimicrob. Agents Chemother.
, vol.24
, pp. 876-882
-
-
Harris, R.1
-
32
-
-
0016193315
-
Role of sweat in accumulation of orally administered griseofulvin in skin
-
Shah V.P., et al. Role of sweat in accumulation of orally administered griseofulvin in skin. J. Clin. Invest. 53 (1974) 1673-1678
-
(1974)
J. Clin. Invest.
, vol.53
, pp. 1673-1678
-
-
Shah, V.P.1
-
33
-
-
0028171976
-
Bioavailability of fluconazole in the skin after oral medication
-
Wildfeuer A., et al. Bioavailability of fluconazole in the skin after oral medication. Mycoses 37 (1994) 127-130
-
(1994)
Mycoses
, vol.37
, pp. 127-130
-
-
Wildfeuer, A.1
-
34
-
-
0027532417
-
Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat
-
Faergemann J., et al. Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat. Clin. Exp. Dermatol. 18 (1993) 102-106
-
(1993)
Clin. Exp. Dermatol.
, vol.18
, pp. 102-106
-
-
Faergemann, J.1
-
35
-
-
0031003863
-
Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli
-
Asako H., et al. Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli. Appl. Environ. Microbiol. 63 (1997) 1428-1433
-
(1997)
Appl. Environ. Microbiol.
, vol.63
, pp. 1428-1433
-
-
Asako, H.1
-
36
-
-
0141613653
-
Evaluation of ofloxacin penetration into the skin after a single oral dose assessed by cutaneous microdialysis
-
Bielecka-Grzela S., et al. Evaluation of ofloxacin penetration into the skin after a single oral dose assessed by cutaneous microdialysis. Pol. J. Pharmacol. 55 (2003) 613-618
-
(2003)
Pol. J. Pharmacol.
, vol.55
, pp. 613-618
-
-
Bielecka-Grzela, S.1
-
37
-
-
0031822413
-
The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin
-
Berry G., et al. The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin. Ann. Oncol. 9 (1998) 711-716
-
(1998)
Ann. Oncol.
, vol.9
, pp. 711-716
-
-
Berry, G.1
-
38
-
-
17244370519
-
Detection of doxorubicin in the horny layer in a patient suffering from palmar-plantar erythrodysaesthesia
-
Schmook T., et al. Detection of doxorubicin in the horny layer in a patient suffering from palmar-plantar erythrodysaesthesia. Dermatology 210 (2005) 237-238
-
(2005)
Dermatology
, vol.210
, pp. 237-238
-
-
Schmook, T.1
-
39
-
-
25444472043
-
Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?
-
Jacobi U., et al. Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?. Ann. Oncol. 16 (2005) 1210-1211
-
(2005)
Ann. Oncol.
, vol.16
, pp. 1210-1211
-
-
Jacobi, U.1
-
40
-
-
0032750706
-
Number of cell layers of the stratum corneum in normal skin - relationship to the anatomical location on the body, age, sex and physical parameters
-
Ya-Xian Z., et al. Number of cell layers of the stratum corneum in normal skin - relationship to the anatomical location on the body, age, sex and physical parameters. Arch. Dermatol. Res. 291 (1999) 555-559
-
(1999)
Arch. Dermatol. Res.
, vol.291
, pp. 555-559
-
-
Ya-Xian, Z.1
-
41
-
-
0025822956
-
Peak blistering point: influence on fluid levels of 5-MOP in human skin in vivo after systemic administration
-
Humbert P., et al. Peak blistering point: influence on fluid levels of 5-MOP in human skin in vivo after systemic administration. Arch. Dermatol. Res. 283 (1991) 297-299
-
(1991)
Arch. Dermatol. Res.
, vol.283
, pp. 297-299
-
-
Humbert, P.1
-
42
-
-
0026605820
-
A new micronized 5-methoxypsoralen preparation. Higher bioavailability and lower UVA dose requirement
-
Treffel P., et al. A new micronized 5-methoxypsoralen preparation. Higher bioavailability and lower UVA dose requirement. Acta Derm. Venereol. 72 (1992) 65-67
-
(1992)
Acta Derm. Venereol.
, vol.72
, pp. 65-67
-
-
Treffel, P.1
-
43
-
-
0035720276
-
Plasma and skin concentration of 5-methoxypsoralen in psoriatic patients after oral administration
-
Zucchi A., et al. Plasma and skin concentration of 5-methoxypsoralen in psoriatic patients after oral administration. J. Invest. Dermatol. 117 (2001) 379-382
-
(2001)
J. Invest. Dermatol.
, vol.117
, pp. 379-382
-
-
Zucchi, A.1
-
44
-
-
12844276474
-
Orally administered ethanol: transepidermal pathways and effects on the human skin barrier
-
Jacobi U., et al. Orally administered ethanol: transepidermal pathways and effects on the human skin barrier. Arch. Dermatol. Res. 296 (2005) 332-338
-
(2005)
Arch. Dermatol. Res.
, vol.296
, pp. 332-338
-
-
Jacobi, U.1
-
45
-
-
0035726450
-
Cutaneous elimination of 2,3,7,8-tetrachlorodibenzo-p-dioxin
-
Geusau A., et al. Cutaneous elimination of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Br. J. Dermatol. 145 (2001) 938-943
-
(2001)
Br. J. Dermatol.
, vol.145
, pp. 938-943
-
-
Geusau, A.1
-
46
-
-
0028295329
-
The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity
-
van den Berg M., et al. The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity. Crit. Rev. Toxicol. 24 (1994) 1-74
-
(1994)
Crit. Rev. Toxicol.
, vol.24
, pp. 1-74
-
-
van den Berg, M.1
-
47
-
-
0037230454
-
In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application
-
Colombo G., et al. In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application. Skin Pharmacol. Appl. Skin Physiol. 16 (2003) 130-136
-
(2003)
Skin Pharmacol. Appl. Skin Physiol.
, vol.16
, pp. 130-136
-
-
Colombo, G.1
-
48
-
-
15644369790
-
The metabolism of griseofulvin in mammals
-
Barnes M.J., et al. The metabolism of griseofulvin in mammals. Biochem. J. 78 (1961) 41-43
-
(1961)
Biochem. J.
, vol.78
, pp. 41-43
-
-
Barnes, M.J.1
-
49
-
-
34347213752
-
Follicular penetration of topically applied caffeine via a shampoo formulation
-
Otberg N., et al. Follicular penetration of topically applied caffeine via a shampoo formulation. Skin Pharmacol. Physiol. 20 (2007) 195-198
-
(2007)
Skin Pharmacol. Physiol.
, vol.20
, pp. 195-198
-
-
Otberg, N.1
-
50
-
-
0029895587
-
Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus
-
Baraka O.Z., et al. Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus. Eur. J. Clin. Pharmacol. 50 (1996) 407-410
-
(1996)
Eur. J. Clin. Pharmacol.
, vol.50
, pp. 407-410
-
-
Baraka, O.Z.1
|